United States · Law · HR
H.R. 6228 (98th)
An act providing for an extension until April 21, 1992, of five patents relating to oral hypoglycemic drugs of the sulfonylurea class.
Introduced
12 September 1984
Last action
—
Status
Became Private Law No: 98-46.
Sponsors
—
Subjects
Discovery layer
Source updated
16 January 2025
Summary
Amends the patent laws to extend the term of any patent encompassing a new drug product subject to the labeling requirements for oral hypoglycemic drugs of the sulfonylurea class as promulgated by the Food and Drug Administration on a specified date.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
2 official files
Private Law (PDF)
Private Law (PDF)
Private Law · EN · 20 October 1984
Introduced in House
summary · EN · 12 September 1984
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/98th-congress/house-bill/6228
- Open data entity: https://api.congress.gov/v3/bill/98/hr/6228